Oncogenic proteins as tumor antigens

Area of Science:

• Immunology
• Oncology
• Cancer Research

Background:

• Human immune responses to oncogenic proteins are increasingly recognized.
• Immunity has been identified against both overexpressed and mutated oncoproteins.
• This understanding is crucial for developing novel cancer therapies.

Purpose of the Study:

• To summarize the current understanding of human immune responses to oncogenic proteins.
• To highlight the identification of immunity against various types of oncoproteins.
• To underscore the translational potential of these findings in cancer treatment.

Main Methods:

• Literature review and synthesis of existing research on immune responses to oncogenic proteins.
• Analysis of studies identifying immune recognition of both mutated and non-mutated oncoproteins.
• Examination of preclinical and clinical data on immunotherapy targeting oncoproteins.

Main Results:

• Human immune responses targeting oncogenic proteins have been identified.
• Immunity is directed against a spectrum of oncoproteins, including overexpressed and mutated forms.
• Immune-based treatments targeting oncogenic proteins demonstrate efficacy in preclinical models.

Conclusions:

• The human immune system actively targets oncogenic proteins.
• Targeting these proteins with immunotherapies holds significant therapeutic promise.
• Ongoing clinical trials are evaluating the efficacy of these immune-based treatments in cancer patients.